(Q37039588)

17 August 2017

1 reference

title

Immunological aspects of cancer chemotherapy (English)

1 reference

17 August 2017

1 reference

1

Laurence Zitvogel

0 references

Guido Kroemer

series ordinal

4

object named as

Guido Kroemer

0 references

François Ghiringhelli

series ordinal

3

object named as

François Ghiringhelli

0 references

Lionel Apetoh

series ordinal

2

object named as

Lionel Apetoh

0 references

publication date

1 January 2008

1 reference

Nature Reviews Immunology

17 August 2017

1 reference

17 August 2017

8

1 reference

17 August 2017

59-73

1 reference

17 August 2017

1

1 reference

Cancer despite immunosurveillance: immunoselection and immunosubversion

17 August 2017

1 reference

Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development

31 March 2020

1 reference

Cancer immunologists and cancer biologists: why we didn't talk then but need to now

31 March 2020

1 reference

Treatment of multiple sclerosis with cyclophosphamide: critical review of clinical and immunologic effects

31 March 2020

1 reference

Efficacy of low-dose methotrexate in rheumatoid arthritis

31 March 2020

1 reference

Imatinib inhibits T-cell receptor-mediated T-cell proliferation and activation in a dose-dependent manner

31 March 2020

1 reference

Imatinib mesylate selectively impairs expansion of memory cytotoxic T cells without affecting the control of primary viral infections.

31 March 2020

1 reference

Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells

31 March 2020

1 reference

Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors.

31 March 2020

1 reference

Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2- versus IL-15-activated NK cells

31 March 2020

1 reference

Calreticulin exposure dictates the immunogenicity of cancer cell death

31 March 2020

1 reference

One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases

31 March 2020

1 reference

Cytokine levels and systemic toxicity in patients undergoing isolated limb perfusion with high-dose tumor necrosis factor, interferon gamma, and melphalan

31 March 2020

1 reference

A cytokine-mediated link between innate immunity, inflammation, and cancer

31 March 2020

1 reference

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

31 March 2020

1 reference

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

31 March 2020

1 reference

Late and persistent up-regulation of intercellular adhesion molecule-1 (ICAM-1) expression by ionizing radiation in human endothelial cells in vitro

31 March 2020

1 reference

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

31 March 2020

1 reference

Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor

31 March 2020

1 reference

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

31 March 2020

1 reference

CpG oligodeoxynucleotide enhances tumor response to radiation

31 March 2020

1 reference

Increased intensity lymphodepletion and adoptive immunotherapy--how far can we go?

31 March 2020

1 reference

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

31 March 2020

1 reference

Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells

31 March 2020

1 reference

Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma

31 March 2020

1 reference

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

31 March 2020

1 reference

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

31 March 2020

1 reference

Accelerated CD8+ T-cell memory and prime-boost response after dendritic-cell vaccination.

31 March 2020

1 reference

Hematopoietic stem cells promote the expansion and function of adoptively transferred antitumor CD8 T cells

31 March 2020

1 reference

Effect of Cyclophosphamide on Immunological Control Mechanisms

31 March 2020

1 reference

Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

31 March 2020

1 reference

Regulation of specific cell-mediated cytotoxic response against SV40-induced tumor associated antigens by depletion of suppressor T cells with cyclophosphamide in mice

31 March 2020

1 reference

Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses

31 March 2020

1 reference

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

31 March 2020

1 reference

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

31 March 2020

1 reference

Effective chemo-immunotherapy of L1210 leukemia in vivo using interleukin-12 combined with doxorubicin but not with cyclophosphamide, paclitaxel or cisplatin.

31 March 2020

1 reference

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

31 March 2020

1 reference

The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol

31 March 2020

1 reference

Efficacy of GM-CSF-producing tumor vaccine after docetaxel chemotherapy in mice bearing established Lewis lung carcinoma

31 March 2020

1 reference

Cellular immunity in breast cancer patients completing taxane treatment

31 March 2020

1 reference

B cells inhibit induction of T cell-dependent tumor immunity.

31 March 2020

1 reference

Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity

31 March 2020

1 reference

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

31 March 2020

1 reference

Effect of gemcitabine on immune cells in subjects with adenocarcinoma of the pancreas

31 March 2020

1 reference

Phase I study of gemcitabine given weekly as a short infusion for non-small cell lung cancer: results and possible immune system-related mechanisms

31 March 2020

1 reference

Chemo-immunotherapy of metastatic colorectal carcinoma with gemcitabine plus FOLFOX 4 followed by subcutaneous granulocyte macrophage colony-stimulating factor and interleukin-2 induces strong immunologic and antitumor activity in metastatic colon c

31 March 2020

1 reference

Drug- and cell-mediated antitumor cytotoxicities modulate cross-presentation of tumor antigens by myeloid dendritic cells

31 March 2020

1 reference

Intratumoral injection of dendritic cells after treatment of anticancer drugs induces tumor-specific antitumor effect in vivo

31 March 2020

1 reference

5-fluorouracil-based chemotherapy enhances the antitumor activity of a thymidylate synthase-directed polyepitopic peptide vaccine.

31 March 2020

1 reference

Rexpression of HLA class I antigens and restoration of antigen-specific CTL response in melanoma cells following 5-aza-2'-deoxycytidine treatment

31 March 2020

1 reference

Antivascular therapy of cancer: DMXAA.

31 March 2020

1 reference

Activation of tumor-associated macrophages by the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid induces an effective CD8+ T-cell-mediated antitumor immune response in murine models of lung cancer and mesothelioma

31 March 2020

1 reference

The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis

31 March 2020

1 reference

Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell-dependent antitumor effects

31 March 2020

1 reference

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

31 March 2020

1 reference

A novel dendritic cell subset involved in tumor immunosurveillance

31 March 2020

1 reference

Immunotherapy and chemotherapy--a practical partnership

31 March 2020

1 reference

Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells.

31 March 2020

1 reference

Immunotherapy for human cancer using heat shock protein-peptide complexes

31 March 2020

1 reference

Peptides chaperoned by heat-shock proteins are a necessary and sufficient source of antigen in the cross-priming of CD8+ T cells

31 March 2020

1 reference

Combination of imatinib mesylate with autologous leukocyte-derived heat shock protein and chronic myelogenous leukemia

31 March 2020

1 reference

Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications

31 March 2020

1 reference

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

31 March 2020

1 reference

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

31 March 2020

1 reference

Ecto-calreticulin in immunogenic chemotherapy

31 March 2020

1 reference

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

31 March 2020

1 reference

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

31 March 2020

1 reference

Inhibitory effect of Toll-like receptor 4 on fusion between phagosomes and endosomes/lysosomes in macrophages

31 March 2020

1 reference

Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer

31 March 2020

1 reference

Unexpected association between induction of immunity to the universal tumor antigen CYP1B1 and response to next therapy.

31 March 2020

1 reference

A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer

31 March 2020

1 reference

Immunological evaluation of individualized peptide vaccination with a low dose of estramustine for HLA-A24+ HRPC patients

31 March 2020

1 reference

FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer.

31 March 2020

1 reference

Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma

31 March 2020

1 reference

Polymorphisms of interleukin (IL)-1alpha, IL-1beta, IL-6, IL-10, and IL-18 and the risk of ovarian cancer

31 March 2020

1 reference

Antibodies, Fc receptors and cancer

31 March 2020

1 reference

Classification of cell death: recommendations of the Nomenclature Committee on Cell Death

31 March 2020

1 reference

Immune response against dying tumor cells

31 March 2020

1 reference

Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma

31 March 2020

1 reference

Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical Trial

31 March 2020

1 reference

The immunological effects of taxanes

31 March 2020

1 reference

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

31 March 2020

1 reference

Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T cells

31 March 2020

1 reference

Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments

31 March 2020

1 reference

CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative

31 March 2020

1 reference

Restoration of macrophage tumoricidal activity by bleomycin correlates with the decreased production of transforming growth factor beta in rats bearing KDH-8 hepatoma cells

31 March 2020

1 reference

Immunomodulation of Natural Killer Cell Activity by Flavone Acetic Acid: Occurrence Via Induction of Interferon /beta

31 March 2020

1 reference

Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group

31 March 2020

1 reference

Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma

31 March 2020

1 reference

Short communication: the efficacy of fixed dose rate infusion of gemcitabine combined with IFN-alpha2a in patients with advanced refractory renal cell carcinoma

31 March 2020

1 reference

Interleukin-2- and interferon alfa-2a-based immunochemotherapy in advanced renal cell carcinoma: a Prospectively Randomized Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN).

31 March 2020

1 reference

Combined regimen of cisplatin, doxorubicin, and alpha-2b interferon in the treatment of advanced malignant pleural mesothelioma: a Phase II multicenter trial of the Italian Group on Rare Tumors (GITR) and the Italian Lung Cancer Task Force (FONICAP)

31 March 2020

1 reference

Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer

31 March 2020

1 reference

Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia

31 March 2020

1 reference

Chemo-immunotherapy and chemo-adoptive immunotherapy of cancer

31 March 2020

1 reference

Cancer; a biological approach. I. The processes of control

31 March 2020

1 reference

Decreased tumor surveillance in perforin-deficient mice

31 March 2020

1 reference

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

31 March 2020

1 reference

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

31 March 2020

1 reference

Enhancing the effect of THERATOPE STn-KLH cancer vaccine in patients with metastatic breast cancer by pretreatment with low-dose intravenous cyclophosphamide

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRI2216

1 reference

17 August 2017

1 reference

PubMed ID

18097448